520 related articles for article (PubMed ID: 16116224)
41. Toll-like receptor 2 stimulation decreases IFN-gamma receptor expression in mouse RAW264.7 macrophages.
Curry H; Alvarez GR; Zwilling BS; Lafuse WP
J Interferon Cytokine Res; 2004 Dec; 24(12):699-710. PubMed ID: 15684737
[TBL] [Abstract][Full Text] [Related]
42. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.
Underhill DM; Ozinsky A; Smith KD; Aderem A
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14459-63. PubMed ID: 10588727
[TBL] [Abstract][Full Text] [Related]
43. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.
Fremond CM; Togbe D; Doz E; Rose S; Vasseur V; Maillet I; Jacobs M; Ryffel B; Quesniaux VF
J Immunol; 2007 Jul; 179(2):1178-89. PubMed ID: 17617611
[TBL] [Abstract][Full Text] [Related]
44. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.
Zhai Y; Shen XD; O'Connell R; Gao F; Lassman C; Busuttil RW; Cheng G; Kupiec-Weglinski JW
J Immunol; 2004 Dec; 173(12):7115-9. PubMed ID: 15585830
[TBL] [Abstract][Full Text] [Related]
45. TLR signaling pathways.
Takeda K; Akira S
Semin Immunol; 2004 Feb; 16(1):3-9. PubMed ID: 14751757
[TBL] [Abstract][Full Text] [Related]
46. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.
Henneke P; Takeuchi O; Malley R; Lien E; Ingalls RR; Freeman MW; Mayadas T; Nizet V; Akira S; Kasper DL; Golenbock DT
J Immunol; 2002 Oct; 169(7):3970-7. PubMed ID: 12244198
[TBL] [Abstract][Full Text] [Related]
47. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
48. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
49. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
[TBL] [Abstract][Full Text] [Related]
50. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes.
Mizel SB; Honko AN; Moors MA; Smith PS; West AP
J Immunol; 2003 Jun; 170(12):6217-23. PubMed ID: 12794153
[TBL] [Abstract][Full Text] [Related]
51. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism.
Stockinger S; Reutterer B; Schaljo B; Schellack C; Brunner S; Materna T; Yamamoto M; Akira S; Taniguchi T; Murray PJ; Müller M; Decker T
J Immunol; 2004 Dec; 173(12):7416-25. PubMed ID: 15585867
[TBL] [Abstract][Full Text] [Related]
52. STAT1 plays a role in TLR signal transduction and inflammatory responses.
Luu K; Greenhill CJ; Majoros A; Decker T; Jenkins BJ; Mansell A
Immunol Cell Biol; 2014 Oct; 92(9):761-9. PubMed ID: 25027037
[TBL] [Abstract][Full Text] [Related]
53. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.
Bellocchio S; Montagnoli C; Bozza S; Gaziano R; Rossi G; Mambula SS; Vecchi A; Mantovani A; Levitz SM; Romani L
J Immunol; 2004 Mar; 172(5):3059-69. PubMed ID: 14978111
[TBL] [Abstract][Full Text] [Related]
54. Innate immune responses to Rhodococcus equi.
Darrah PA; Monaco MC; Jain S; Hondalus MK; Golenbock DT; Mosser DM
J Immunol; 2004 Aug; 173(3):1914-24. PubMed ID: 15265925
[TBL] [Abstract][Full Text] [Related]
55. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.
Equils O; Schito ML; Karahashi H; Madak Z; Yarali A; Michelsen KS; Sher A; Arditi M
J Immunol; 2003 May; 170(10):5159-64. PubMed ID: 12734363
[TBL] [Abstract][Full Text] [Related]
56. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.
O'Neill LA; Dunne A; Edjeback M; Gray P; Jefferies C; Wietek C
J Endotoxin Res; 2003; 9(1):55-9. PubMed ID: 12691620
[TBL] [Abstract][Full Text] [Related]
57. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62.
Goodridge HS; Marshall FA; Else KJ; Houston KM; Egan C; Al-Riyami L; Liew FY; Harnett W; Harnett MM
J Immunol; 2005 Jan; 174(1):284-93. PubMed ID: 15611251
[TBL] [Abstract][Full Text] [Related]
58. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.
Takeuchi O; Hoshino K; Akira S
J Immunol; 2000 Nov; 165(10):5392-6. PubMed ID: 11067888
[TBL] [Abstract][Full Text] [Related]
59. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes.
Pivarcsi A; Bodai L; Réthi B; Kenderessy-Szabó A; Koreck A; Széll M; Beer Z; Bata-Csörgoo Z; Magócsi M; Rajnavölgyi E; Dobozy A; Kemény L
Int Immunol; 2003 Jun; 15(6):721-30. PubMed ID: 12750356
[TBL] [Abstract][Full Text] [Related]
60. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans.
Biondo C; Midiri A; Messina L; Tomasello F; Garufi G; Catania MR; Bombaci M; Beninati C; Teti G; Mancuso G
Eur J Immunol; 2005 Mar; 35(3):870-8. PubMed ID: 15714580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
